BAX logo

Baxter International Inc. (BAX)

$26.34

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on BAX

Market cap

$13.62B

EPS

-2.09

P/E ratio

--

Price to sales

1.19

Dividend yield

0.152%

Beta

0.597558

Price on BAX

Previous close

$26.41

Today's open

$26.51

Day's range

$26.09 - $26.67

52 week range

$15.73 - $30

Profile about BAX

CEO

Andrew P. Hider

Employees

37500

Headquarters

Deerfield, IL

Exchange

New York Stock Exchange

Shares outstanding

516995999

Issue type

Common Stock

BAX industries and sectors

Healthcare

Medical Equipment & Supplies

News on BAX

Baxter Appoints John Rogers Chief Financial Officer

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has appointed John Rogers as executive vice president and chief financial officer (CFO), reporting to Baxter president and chief executive officer (CEO), Andrew Hider, effective Oct. 1, 2026. “John is a proven global finance executive with extensive operational expertise and a successful track record leading complex transformation initiatives,” said Hider. “He is an ideal fit for.

news source

Business Wire • Aug 19, 2026

news preview

Baxter Announces Early Tender Results and Upsizing of Previously Announced Cash Tender Offers

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) today announced the early results of its previously announced cash tender offers (each, an “Offer” and collectively, the “Offers”) for its validly tendered (and not validly withdrawn) notes set forth below (collectively, the “Notes”). The Offers are being made pursuant to an Offer to Purchase, dated Aug. 4, 2026 (as it may be amended or supplemented from time to time, the “Offer to Purchase”), whi.

news source

Business Wire • Aug 18, 2026

news preview

Baxter Announces Pricing for Its Upsized Cash Tender Offers

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) today announced the pricing terms for its previously announced cash tender offers (each, an “Offer” and collectively, the “Offers”) of the Company's validly tendered (and not validly withdrawn) notes set forth below (the “Notes”) using a “waterfall” methodology under which the Company will accept the Notes in order of their respective acceptance priority levels noted in the table below (the “Accep.

news source

Business Wire • Aug 18, 2026

news preview

Baxter Announces Cash Tender Offers

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) today announced that it has commenced cash tender offers (each, an “Offer” and collectively, the “Offers”) for the maximum principal amount of validly tendered (and not validly withdrawn) notes set forth below (collectively, the “Notes”), such that the aggregate purchase price, not including accrued and unpaid interest, payable in respect of such Notes will not exceed $500 million. The terms and c.

news source

Business Wire • Aug 4, 2026

news preview

Baxter International: The Gains Can Continue, But Should Slow

Baxter International has shown early signs of a turnaround, with improving execution and raised revenue guidance supporting cautious optimism. BAX's valuation has expanded from distressed levels, now trading at ~13x earnings and ~9.5x EV/EBITDA, yet remains attractive if growth continues. Management's focus on operational improvements, cost savings, and a conservative outlook suggests potential for further upside if EPS growth materializes.

news source

Seeking Alpha • Aug 3, 2026

news preview

Why Baxter International Stock Skyrocketed by 19% This Week

It scored double beats on analyst estimates. It also lifted its guidance on both the top and bottom lines.

news source

The Motley Fool • Aug 1, 2026

news preview

Baxter raises annual profit forecast on strong demand for IV solutions

Medical products maker Baxter International on Thursday raised its annual profit forecast and beat Wall Street estimates for quarterly ​results, banking on robust sales of its medical ‌products such as IV solutions.

news source

Reuters • Jul 30, 2026

news preview

Baxter Jumps After Q2 Beat, Boosted 2026 Guidance Reflects Turnaround Progress

Baxter International Inc. (NYSE:BAX) stock is trading higher on Thursday after the company reported better-than-expected second-quarter financial results and raised its fiscal 2026 guidance.

news source

Benzinga • Jul 30, 2026

news preview

Baxter International Inc. (BAX) Q2 2026 Earnings Call Transcript

Baxter International Inc. (BAX) Q2 2026 Earnings Call Transcript

news source

Seeking Alpha • Jul 30, 2026

news preview

Baxter Reports Second-Quarter 2026 Results

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the second quarter of 2026. “Our second-quarter results exceeded expectations on both the top and bottom lines, driven by both operating performance and an additional benefit from a tariff refund that was not previously contemplated in our guidance,” said Andrew Hider, president and CEO. “While we're encouraged by this steady progress and core operating momentum, we remain.

news source

Business Wire • Jul 30, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Baxter International Inc.

Open an M1 investment account to buy and sell Baxter International Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in BAX on M1